GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocular Therapeutix Inc (STU:0OT) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Ocular Therapeutix (STU:0OT) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Apr. 13, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Ocular Therapeutix Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Ocular Therapeutix's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Ocular Therapeutix's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Ocular Therapeutix's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocular Therapeutix's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocular Therapeutix's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Ocular Therapeutix's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Ocular Therapeutix  (STU:0OT) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Ocular Therapeutix Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Ocular Therapeutix's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocular Therapeutix Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocular Therapeutix Inc (STU:0OT) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
SPRY ETNB VRDN ARDX IOVA ADPT INVA AUPH SNDX NVAX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
OCUL:USA
Address
15 Crosby Drive, Bedford, MA, USA, 01730
Website
https://www.ocutx.com
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Ocular Therapeutix Headlines

No Headlines